CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) designed for research into extended stimulation of growth hormone secretion pathways. It is structurally modified to increase its half-life, allowing for prolonged activity in experimental settings compared to naturally occurring GHRH.
Scientific studies involving CJC-1295 often focus on its interaction with the pituitary gland and its ability to influence pulsatile growth hormone release. Researchers examine its potential role in protein synthesis pathways, metabolic regulation, and recovery-related biological processes.
It is also frequently studied in combination with other peptides in growth hormone secretagogue research, particularly for its sustained signaling effects. Due to its long-acting nature, it is widely used in endocrine and metabolic research models.
For research purposes only.
Reviews
There are no reviews yet.